Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 83,500 | 46,300 | 36,600 | 36,100 | 11,100 |
| Depreciation Amortization | 94,200 | 47,700 | 201,700 | 153,100 | 104,300 |
| Income taxes - deferred | 9,400 | 7,700 | 41,300 | 26,700 | 10,500 |
| Accounts receivable | 59,100 | 63,600 | -11,500 | 56,400 | 41,400 |
| Accounts payable and accrued liabilities | -17,600 | -15,800 | 12,100 | -50,100 | 4,600 |
| Other Working Capital | -300 | 11,700 | -15,900 | -64,100 | 12,500 |
| Other Operating Activity | -39,400 | -43,700 | 88,800 | 62,100 | -1,800 |
| Operating Cash Flow | $188,900 | $117,500 | $353,100 | $220,200 | $182,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34,300 | -10,800 | -66,700 | -44,400 | -27,200 |
| Net Acquisitions | -5,600 | -3,000 | -37,000 | -34,300 | -32,300 |
| Other Investing Activity | -100 | -100 | 2,600 | 100 | -100 |
| Investing Cash Flow | $-40,000 | $-13,900 | $-101,100 | $-78,600 | $-59,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,006,000 | N/A | 261,300 |
| Debt Issued | -10,500 | -6,000 | -998,900 | 186,600 | -74,700 |
| Debt Repayment | N/A | N/A | -74,700 | -1,256,000 | -1,253,500 |
| Common Stock Issued | 2,200 | 800 | 400 | 100 | 100 |
| Common Stock Repurchased | -1,700 | -1,600 | -1,300 | -1,200 | -1,200 |
| Dividend Paid | -66,600 | -33,900 | -129,800 | -97,400 | -64,900 |
| Other Financing Activity | 500 | 300 | -6,000 | 1,000,100 | 1,000,100 |
| Financing Cash Flow | $-76,100 | $-40,400 | $-204,300 | $-167,800 | $-132,800 |
| Beginning Cash Position | 253,000 | 253,000 | 205,300 | 205,300 | 205,300 |
| End Cash Position | 325,800 | 316,200 | 253,000 | 179,100 | 195,500 |
| Net Cash Flow | $72,800 | $63,200 | $47,700 | $-26,200 | $-9,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 188,900 | 117,500 | 353,100 | 220,200 | 182,600 |
| Capital Expenditure | -35,300 | -10,900 | -87,200 | -57,400 | -40,100 |
| Free Cash Flow | 153,600 | 106,600 | 265,900 | 162,800 | 142,500 |